Clinical trials for neurodevelopmental disorders: At a therapeutic frontier
- PMID: 26764154
- DOI: 10.1126/scitranslmed.aad9874
Clinical trials for neurodevelopmental disorders: At a therapeutic frontier
Abstract
A well-powered clinical trial that failed to replicate promising results in animal models of fragile X syndrome yields important lessons for clinical trial design (Berry-Kravis et al., this issue).
Copyright © 2016, American Association for the Advancement of Science.
Comment on
-
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.Sci Transl Med. 2016 Jan 13;8(321):321ra5. doi: 10.1126/scitranslmed.aab4109. Sci Transl Med. 2016. PMID: 26764156 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

